{
    "organizations": [],
    "uuid": "1fb3c78b74087c0437eddb9d28649bd8ce340567",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sun-pharma-industries-says-qtrly-u/brief-sun-pharma-industries-says-qtrly-us-finished-dosage-sales-down-35-pct-idUSFWN1Q40RB",
    "ord_in_thread": 0,
    "title": "BRIEF-Sun Pharma Industries Says Qtrly US Finished Dosage Sales Down 35 Pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Sun Pharmaceutical Industries Ltd :\n* SAYS US FINISHED DOSAGE SALES DURING QUARTER AT US$ 328 MILLION, DOWN 35 PERCENT OVER Q3 LAST YEAR Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T19:17:00.000+02:00",
    "crawled": "2018-02-15T20:31:32.021+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "sun",
        "pharmaceutical",
        "industry",
        "ltd",
        "say",
        "u",
        "finished",
        "dosage",
        "sale",
        "quarter",
        "u",
        "million",
        "percent",
        "q3",
        "last",
        "year",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}